Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
NCT ID: NCT06141486
Last Updated: 2026-01-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE3
900 participants
INTERVENTIONAL
2023-12-27
2028-03-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* This event-driven study will end when the target number of 6-month cCDP events is achieved, and the study is expected to last 43 months from randomization of the first participant to the common study end.
* The number of scheduled visits will be up to 25 (including 3 follow-up visits) with a visit frequency of every month for the first 6 months and then every 3 months.
* If the prespecified number of events for 6-month cCDP is not reached by V21/W180, scheduled visits will continue every 3 months.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
NCT06141473
Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis
NCT04879628
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
NCT07325292
A Study to Evaluate the Effect of SAR443820 on Serum Neurofilament Levels in Male and Female Adult Participants With Multiple Sclerosis
NCT05630547
Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES)
NCT04411641
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Frexalimab
Frexalimab IV administration
Frexalimab
SAR441344 Solution for IV infusion
MRI contrast-enhancing agents
IV, as per respective label
Placebo
Matching placebo
Placebo
Solution for IV infusion
MRI contrast-enhancing agents
IV, as per respective label
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Frexalimab
SAR441344 Solution for IV infusion
Placebo
Solution for IV infusion
MRI contrast-enhancing agents
IV, as per respective label
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participant must have a current diagnosis of SPMS in accordance with the clinical course criteria revised in 2013 endorsed by an Adjudication Committee.
* Participant must have documented evidence of disability progression observed during the 12 months before screening. Eligibility will be analyzed by an Adjudication Committee.
* Absence of clinical relapses for at least 24 months.
* The participant must have an EDSS score at screening from 3.0 to 6.5 points, inclusive.
* Contraceptive use by men and women should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies.
* For patients eligible to be treated with siponimod: 1) does not tolerate it due to side effects or safety reasons, or 2) has failed siponimod treatment due to perceived lack of efficacy, or 3) has declined siponimod treatment.
Exclusion Criteria
* The presence of psychiatric disturbance or substance abuse.
* History, clinical evidence, suspicion or significant risk for thromboembolic events, as well as myocardial infarction, stroke, and/or antiphosholipid syndrome and any participants requiring antithrombotic treatment.
* Current hypogammaglobulinemia defined by immunoglobulin levels (IgG and/or IgM) below the lower limits of normal (LLN) at Screening or a history of primary hypogammaglobulinemia. Patients with a history of secondary hypogammaglobulinemia induced by anti-C20 monoclonal antibodies (eg, ocrelizumab, ofatumumab, ublituximab, rituximab) may be considered for study inclusion provided their immunoglobulin levels are within the normal limits (WNL) at time of Screening.
* A history or presence of disease that can mimic MS symptoms, such as, but not limited to neuromyelitis optica spectrum disorder, systemic lupus erythematosus, Sjogren's syndrome, acute disseminated encephalomyelitis, and myasthenia gravis.
* The participant has sensitivity to any of the study interventions, or components thereof, or has a drug or other allergy that, in the opinion of the Investigator, contraindicates participation in the study.
* The participant was previously exposed to frexalimab.
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sanofi
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alabama Neurology Associates- Site Number : 8400115
Homewood, Alabama, United States
St. Joseph's Hospital and Medical Center- Site Number : 8400139
Phoenix, Arizona, United States
Honor Health Scottsdale Osborn Medical Center- Site Number : 8400074
Scottsdale, Arizona, United States
Perseverance Research Center- Site Number : 8400138
Scottsdale, Arizona, United States
Imaging Endpoints- Site Number : 8400050
Scottsdale, Arizona, United States
Sutter East Bay Medical Foundation - Berkeley- Site Number : 8400134
Berkeley, California, United States
The Neurology Center of Southern California - Carlsbad- Site Number : 8400023
Carlsbad, California, United States
University of California Irvine - School of Medicine- Site Number : 8400143
Irvine, California, United States
University of California San Diego - La Jolla- Site Number : 8400095
La Jolla, California, United States
Kaiser Permanente - Los Angeles Medical Center- Site Number : 8400184
Los Angeles, California, United States
University of Southern California, Los Angeles- Site Number : 8400118
Los Angeles, California, United States
Hoag Memorial Hospital Presbyterian- Site Number : 8400031
Newport Beach, California, United States
Stanford Neuroscience Health Center- Site Number : 8400120
Palo Alto, California, United States
Private Practice - Dr. Regina Berkovich- Site Number : 8400005
West Hollywood, California, United States
University of Colorado - Anschutz Medical Campus- Site Number : 8400001
Aurora, Colorado, United States
Advanced Neurology of Colorado- Site Number : 8400148
Fort Collins, Colorado, United States
Yale University School of Medicine- Site Number : 8400081
New Haven, Connecticut, United States
Hartford Healthcare Medical Group- Site Number : 8400069
Norwich, Connecticut, United States
New England Institute for Clinical Research- Site Number : 8400114
Stamford, Connecticut, United States
MedStar Georgetown University Hospital- Site Number : 8400044
Washington D.C., District of Columbia, United States
Neurology of Central Florida- Site Number : 8400147
Altamonte Springs, Florida, United States
First Choice Neurology - Espinosa Neuroscience Institute- Site Number : 8400169
Boca Raton, Florida, United States
MS & Neuromuscular Center of Excellence- Site Number : 8400015
Clearwater, Florida, United States
Beth Israel Deaconess Medical Center - Fort Myers- Site Number : 8400041
Fort Myers, Florida, United States
Norman Fixel Institute for Neurological Diseases (FIND)- Site Number : 8400054
Gainesville, Florida, United States
Mayo Clinic in Florida- Site Number : 8400093
Jacksonville, Florida, United States
Neurology Associates - Maitland- Site Number : 8400010
Maitland, Florida, United States
University of Miami Hospital- Site Number : 8400177
Miami, Florida, United States
Orlando Health Neuroscience Institute - Downtown Pavilion- Site Number : 8400060
Orlando, Florida, United States
Axiom Clinical Research of Florida- Site Number : 8400049
Tampa, Florida, United States
University of South Florida- Site Number : 8400013
Tampa, Florida, United States
Palm Beach Neurology- Site Number : 8400105
West Palm Beach, Florida, United States
Velocity Clinical Research - Savannah Neurology- Site Number : 8400061
Savannah, Georgia, United States
Joi Life Wellness Group LLC- Site Number : 8400192
Smyrna, Georgia, United States
Rush University Medical Center- Site Number : 8400102
Chicago, Illinois, United States
University of Chicago Medical Center- Site Number : 8400055
Chicago, Illinois, United States
Consultants in Neurology- Site Number : 8400020
Northbrook, Illinois, United States
Springfield Clinic 1st - 900 Building- Site Number : 8400043
Springfield, Illinois, United States
Neuroscience Institute Center- Site Number : 8400053
Merrillville, Indiana, United States
University of Iowa- Site Number : 8400029
Iowa City, Iowa, United States
University of Kansas Medical Center- Site Number : 8400084
Kansas City, Kansas, United States
College Park Family Care Center - Specialty Center- Site Number : 8400032
Overland Park, Kansas, United States
Baptist Health Lexington- Site Number : 8400149
Lexington, Kentucky, United States
NeuroMedical Clinic of Central Louisiana- Site Number : 8400159
Alexandria, Louisiana, United States
The NeuroMedical Center- Site Number : 8400182
Baton Rouge, Louisiana, United States
Ochsner Medical Center - Jefferson Highway- Site Number : 8400027
New Orleans, Louisiana, United States
University of Maryland School of Medicine - Baltimore- Site Number : 8400185
Baltimore, Maryland, United States
Johns Hopkins Hospital- Site Number : 8400080
Baltimore, Maryland, United States
International Neurorehabilitation Institute- Site Number : 8400089
Lutherville, Maryland, United States
Tufts Medical Center- Site Number : 8400003
Boston, Massachusetts, United States
Boston Clinical Trials- Site Number : 8400178
Boston, Massachusetts, United States
Neurology Center of New England- Site Number : 8400164
Foxborough, Massachusetts, United States
The Elliot Lewis Center- Site Number : 8400033
Wellesley, Massachusetts, United States
UMass Memorial Medical Center - University Campus- Site Number : 8400028
Worcester, Massachusetts, United States
Henry Ford Hospital- Site Number : 8400091
Detroit, Michigan, United States
Michigan Institute for Neurological Disorders- Site Number : 8400004
Farmington Hills, Michigan, United States
Trinity Health Grand Rapids- Site Number : 8400150
Grand Rapids, Michigan, United States
Memorial Healthcare Institute for Neuroscience- Site Number : 8400123
Owosso, Michigan, United States
Rochester Medical Group- Site Number : 8400172
Rochester Hills, Michigan, United States
Minneapolis Clinic of Neurology - Golden Valley- Site Number : 8400077
Golden Valley, Minnesota, United States
M Health Fairview University of Minnesota Medical Center - East Bank- Site Number : 8400056
Minneapolis, Minnesota, United States
Minnesota Center for Multiple Sclerosis- Site Number : 8400073
Plymouth, Minnesota, United States
Sharlin Health and Neurology- Site Number : 8400016
Ozark, Missouri, United States
Washington University- Site Number : 8400076
St Louis, Missouri, United States
Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas- Site Number : 8400045
Las Vegas, Nevada, United States
Renown Regional Medical Center- Site Number : 8400066
Reno, Nevada, United States
Dartmouth-Hitchcock Medical Center - Lebanon - 1 Medical Center Drive- Site Number : 8400098
Lebanon, New Hampshire, United States
Rutgers University- Site Number : 8400067
New Brunswick, New Jersey, United States
Holy Name Medical Center- Site Number : 8400101
Teaneck, New Jersey, United States
The University of New Mexico- Site Number : 8400090
Albuquerque, New Mexico, United States
Dent Neurologic Institute - Amherst- Site Number : 8400129
Amherst, New York, United States
Icahn School of Medicine at Mount Sinai- Site Number : 8400011
New York, New York, United States
Columbia University Irving Medical Center- Site Number : 8400088
New York, New York, United States
Stony Brook University- Site Number : 8400094
Stony Brook, New York, United States
Piedmont HealthCare - Lake Norman Neurology- Site Number : 8400002
Charlotte, North Carolina, United States
Raleigh Neurology Associates- Site Number : 8400014
Raleigh, North Carolina, United States
Atrium Health - Wake Forest Baptist - Shepherd- Site Number : 8400040
Winston-Salem, North Carolina, United States
Sanford Brain and Spine Center- Site Number : 8400085
Fargo, North Dakota, United States
Riverhills Neuroscience- Site Number : 8400007
Cincinnati, Ohio, United States
University of Cincinnati Medical Center- Site Number : 8400117
Cincinnati, Ohio, United States
The Ohio State University- Site Number : 8400009
Columbus, Ohio, United States
The Boster Center for Multiple Sclerosis- Site Number : 8400006
Columbus, Ohio, United States
UC Health - Elizabeth Place- Site Number : 8400008
Dayton, Ohio, United States
Oklahoma Medical Research Foundation- Site Number : 8400039
Oklahoma City, Oklahoma, United States
Providence St. Vincent's Medical Center- Site Number : 8400052
Portland, Oregon, United States
Penn State Health Milton South Hershey Medical Center- Site Number : 8400176
Hershey, Pennsylvania, United States
Thomas Jefferson University Hospital- Site Number : 8400035
Philadelphia, Pennsylvania, United States
Premier Neurology- Site Number : 8400047
Greer, South Carolina, United States
Hope Neurology- Site Number : 8400019
Knoxville, Tennessee, United States
Vanderbilt Multiple Sclerosis Center- Site Number : 8400130
Nashville, Tennessee, United States
Neurology Consultants of Dallas - Lyndon B Johnson Freeway- Site Number : 8400152
Dallas, Texas, United States
North Texas Institute of Neurology & Headache - Plano- Site Number : 8400083
Plano, Texas, United States
Neurology Center of San Antonio- Site Number : 8400099
San Antonio, Texas, United States
Texas Institute for Neurological Disorders - Sherman- Site Number : 8400018
Sherman, Texas, United States
University of Vermont Medical Center- Site Number : 8400042
Burlington, Vermont, United States
Inova Schar Cancer Institute - Fairfax - Innovation Park Drive- Site Number : 8400109
Fairfax, Virginia, United States
Riverside Neurology Specialists - Newport News- Site Number : 8400132
Newport News, Virginia, United States
Multiple Sclerosis Center of Greater Washington (MSCGW)- Site Number : 8400128
Vienna, Virginia, United States
Sentara Family Medicine Physicians - Virginia Beach - Glenn Mitchell Drive- Site Number : 8400168
Virginia Beach, Virginia, United States
Swedish Medical Center - Seattle- Site Number : 8400078
Seattle, Washington, United States
West Virginia University School of Medicine- Site Number : 8400131
Morgantown, West Virginia, United States
Wheaton Franciscan Healthcare - St Francis- Site Number : 8400034
Milwaukee, Wisconsin, United States
Medical College of Wisconsin - Milwaukee Campus- Site Number : 8400038
Milwaukee, Wisconsin, United States
Investigational Site Number : 0320003
Rosario, Santa Fe Province, Argentina
Investigational Site Number : 0320002
Buenos Aires, , Argentina
Investigational Site Number : 0321010
Buenos Aires, , Argentina
Investigational Site Number : 0320007
Buenos Aires, , Argentina
Investigational Site Number : 0320001
Buenos Aires, , Argentina
Investigational Site Number : 0360005
Saint Leonards, New South Wales, Australia
Investigational Site Number : 0360001
Woolloongabba, Queensland, Australia
Investigational Site Number : 0360002
Melbourne, Victoria, Australia
Investigational Site Number : 0560001
Bruges, , Belgium
Investigational Site Number : 0560008
Brussels, , Belgium
Investigational Site Number : 0560006
Ghent, , Belgium
Investigational Site Number : 0560007
Kortrijk, , Belgium
Investigational Site Number : 0560003
Melsbroek, , Belgium
Investigational Site Number : 0560005
Overpelt, , Belgium
Centro de Diagnostico e Pesquisa da Osteoporose do Espirito Santo- Site Number : 0760029
Vitória, Espírito Santo, Brazil
Centro de Pesquisas da Clínica IBIS- Site Number : 0760030
Salvador, Estado de Bahia, Brazil
L2IP - Instituto de Pesquisas Clínicas- Site Number : 0760003
Brasília, Federal District, Brazil
Universidade Federal de Goias- Site Number : 0760024
Goiânia, Goiás, Brazil
Freire Pesquisa Clínica - Belo Horizonte - Rua Piauí- Site Number : 0760025
Belo Horizonte, Minas Gerais, Brazil
Instituto de Neurologia de Curitiba - Ecoville- Site Number : 0760001
Curitiba, Paraná, Brazil
Hospital Moinhos de Vento- Site Number : 0760005
Porto Alegre, Rio Grande do Sul, Brazil
IMV Pesquisa Neurológica- Site Number : 0760031
Porto Alegre, Rio Grande do Sul, Brazil
Instituto Ceos- Site Number : 0760028
Porto Alegre, Rio Grande do Sul, Brazil
Clínica Neurológica- Site Number : 0760007
Joinville, Santa Catarina, Brazil
Prognosis Centro de Pesquisa- Site Number : 0760032
Santo André, São Paulo, Brazil
CPHosp Medicina, Ensino e Pesquisa (CPQuali)- Site Number : 0760002
São Paulo, , Brazil
PSEG Centro de Pesquisa Clínica- Site Number : 0760021
São Paulo, , Brazil
Jordy Sinapse- Site Number : 0760004
São Paulo, , Brazil
Hospital Israelita Albert Einstein- Site Number : 0760026
São Paulo, , Brazil
Investigational Site Number : 1000009
Blagoevgrad, , Bulgaria
Investigational Site Number : 1000008
Panagyurishte, , Bulgaria
Investigational Site Number : 1000007
Pazardzhik, , Bulgaria
Investigational Site Number : 1000002
Pleven, , Bulgaria
Investigational Site Number : 1000010
Pleven, , Bulgaria
Investigational Site Number : 1000004
Sofia, , Bulgaria
Investigational Site Number : 1000001
Sofia, , Bulgaria
Investigational Site Number : 1000006
Sofia, , Bulgaria
Investigational Site Number : 1000005
Sofia, , Bulgaria
Investigational Site Number : 1240011
Calgary, Alberta, Canada
Investigational Site Number : 1240005
Burnaby, British Columbia, Canada
Investigational Site Number : 1240010
Vancouver, British Columbia, Canada
Investigational Site Number: 1240018
Moncton, New Brunswick, Canada
Investigational Site Number : 1240014
London, Ontario, Canada
Investigational Site Number : 1240002
Ottawa, Ontario, Canada
Investigational Site Number : 1240015
Toronto, Ontario, Canada
Investigational Site Number : 1240012
Toronto, Ontario, Canada
Investigational Site Number : 1240001
Gatineau, Quebec, Canada
Investigational Site Number : 1240008
Lévis, Quebec, Canada
Investigational Site Number : 1240009
Montreal, Quebec, Canada
Investigational Site Number : 1240016
Pointe-Claire, Quebec, Canada
Investigational Site Number : 1240003
Québec, Quebec, Canada
Investigational Site Number : 1240006
Sherbrooke, Quebec, Canada
Investigational Site Number : 1520003
Las Condes, Reg Metropolitana de Santiago, Chile
Investigational Site Number : 1520002
Santiago, Reg Metropolitana de Santiago, Chile
Investigational Site Number : 1520001
Santiago, Reg Metropolitana de Santiago, Chile
Investigational Site Number : 1560007
Beijing, , China
Investigational Site Number : 1560005
Beijing, , China
Investigational Site Number : 1560008
Beijing, , China
Investigational Site Number : 1560003
Changchun, , China
Investigational Site Number : 1560011
Changsha, , China
Investigational Site Number : 1560004
Chengdu, , China
Investigational Site Number : 1560045
Fuzhou, , China
Investigational Site Number : 1560002
Guangzhou, , China
Investigational Site Number : 1561027
Harbin, , China
Investigational Site Number : 1560010
Jiazhuang, , China
Investigational Site Number : 1560001
Shanghai, , China
Investigational Site Number : 1560006
Taiyuan, , China
Investigational Site Number : 1560012
Tianjin, , China
Investigational Site Number : 1560009
Wuhan, , China
Investigational Site Number : 1560013
Xi'an, , China
Investigational Site Number : 1560034
Zhengzhou, , China
Investigational Site Number : 2030011
Brno, , Czechia
Investigational Site Number : 2030005
Brno, , Czechia
Investigational Site Number : 2030002
Hradec Králové, , Czechia
Investigational Site Number : 2030006
Jihlava, , Czechia
Investigational Site Number : 2030007
Ostrava, , Czechia
Investigational Site Number : 2030008
Prague, , Czechia
Investigational Site Number : 2030009
Teplice, , Czechia
Investigational Site Number : 2030001
Zlín, , Czechia
Investigational Site Number : 2500011
Bron, , France
Investigational Site Number : 2500005
Créteil, , France
Investigational Site Number : 2500017
Gonesse, , France
Investigational Site Number : 2500006
La Tronche, , France
Investigational Site Number : 2500009
Lille, , France
Investigational Site Number : 2500015
Montpellier, , France
Investigational Site Number : 2500016
Nancy, , France
Investigational Site Number : 2500002
Nice, , France
Investigational Site Number : 2500018
Orsay, , France
Investigational Site Number : 2500007
Paris, , France
Investigational Site Number : 2500014
Paris, , France
Investigational Site Number : 2500003
Rennes, , France
Investigational Site Number : 2500010
Saint-Herblain, , France
Investigational Site Number : 2500001
Strasbourg, , France
Investigational Site Number : 2760009
Bielefeld, , Germany
Investigational Site Number : 2760010
Bochum, , Germany
Investigational Site Number : 2760012
Dresden, , Germany
Investigational Site Number : 2760002
Düsseldorf, , Germany
Investigational Site Number : 2760013
Erbach im Odenwald, , Germany
Investigational Site Number : 2760014
Heidelberg, , Germany
Investigational Site Number : 2760007
Jena, , Germany
Investigational Site Number : 2760003
Leipzig, , Germany
Investigational Site Number : 2760008
Marburg, , Germany
Investigational Site Number : 2760006
Münster, , Germany
Investigational Site Number : 2760001
Ulm, , Germany
Investigational Site Number : 3000003
Athens, , Greece
Investigational Site Number : 3000005
Athens, , Greece
Investigational Site Number : 3000004
Ioannina, , Greece
Investigational Site Number : 3000001
Larissa, , Greece
Investigational Site Number : 3000002
Thessaloniki, , Greece
Investigational Site Number : 3480003
Budapest, , Hungary
Investigational Site Number : 3480004
Budapest, , Hungary
Investigational Site Number : 3480006
Budapest, , Hungary
Investigational Site Number : 3480002
Győr, , Hungary
Investigational Site Number : 3560024
Bengaluru, , India
Investigational Site Number : 3560008
Hyderabad, , India
Investigational Site Number : 3560017
New Delhi, , India
Investigational Site Number : 3560006
Shimla, , India
Investigational Site Number : 3800034
Augusta, Catania, Italy
Investigational Site Number : 3800025
Cona, Ferrara, Italy
Investigational Site Number : 3800004
Florence, Firenze, Italy
Investigational Site Number : 3800011
Genoa, Genova, Italy
Investigational Site Number : 3800008
Pozzilli, Isernia, Italy
Investigational Site Number : 3800002
Milan, Milano, Italy
Investigational Site Number : 3800016
Milan, Milano, Italy
Investigational Site Number : 3800010
Naples, Napoli, Italy
Investigational Site Number : 3800006
Cefalù, Palermo, Italy
Investigational Site Number : 3800015
Rome, Roma, Italy
Investigational Site Number : 3800001
Rome, Roma, Italy
Investigational Site Number : 3800013
Rome, Roma, Italy
Investigational Site Number : 3800021
Rome, Roma, Italy
Investigational Site Number : 3800035
Gallarate, Varese, Italy
Investigational Site Number : 3800009
Bologna, , Italy
Investigational Site Number : 3800014
Chieti, , Italy
Investigational Site Number : 3800019
Foggia, , Italy
Investigational Site Number : 3800026
Novara, , Italy
Investigational Site Number : 3800017
Palermo, , Italy
Investigational Site Number : 3800029
Parma, , Italy
Investigational Site Number : 3800005
Pavia, , Italy
Investigational Site Number : 3800003
Perugia, , Italy
Investigational Site Number : 3800030
Ravenna, , Italy
Investigational Site Number : 3920003
Kōriyama, Fukushima, Japan
Investigational Site Number : 3920014
Asahikawa, Hokkaido, Japan
Investigational Site Number : 3920007
Himeji, Hyōgo, Japan
Investigational Site Number : 3920010
Sagamihara, Kanagawa, Japan
Investigational Site Number : 3920015
Higashi-Matsuyama, Saitama, Japan
Investigational Site Number : 3920016
Kodaira, Tokyo, Japan
Investigational Site Number : 3920002
Chiba, , Japan
Investigational Site Number : 3920013
Fukuoka, , Japan
Investigational Site Number : 3920001
Kyoto, , Japan
Investigational Site Number : 3920011
Tokyo, , Japan
Investigational Site Number : 3920012
Tokyo, , Japan
Investigational Site Number : 5280002
Rotterdam, , Netherlands
Investigational Site Number : 6160002
Plewiska, Greater Poland Voivodeship, Poland
Investigational Site Number : 6160012
Poznan, Greater Poland Voivodeship, Poland
Investigational Site Number : 6160018
Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
Investigational Site Number : 6160005
Krakow, Lesser Poland Voivodeship, Poland
Investigational Site Number : 6160006
Rzeszów, Podkarpackie Voivodeship, Poland
Investigational Site Number : 6160007
Bialystok, Podlaskie Voivodeship, Poland
Investigational Site Number : 6160010
Katowice, Silesian Voivodeship, Poland
Investigational Site Number : 6160011
Katowice, Silesian Voivodeship, Poland
Investigational Site Number : 6160004
Zabrze, Silesian Voivodeship, Poland
Investigational Site Number : 6200001
Braga, , Portugal
Investigational Site Number : 6200011
Lisbon, , Portugal
Investigational Site Number : 6200007
Lisbon, , Portugal
Investigational Site Number : 6200006
Lisbon, , Portugal
Investigational Site Number : 6200002
Matosinhos Municipality, , Portugal
Investigational Site Number : 6820001
Riyadh, , Saudi Arabia
Investigational Site Number : 4100001
Goyang-si, Gyeonggi-do, South Korea
Investigational Site Number : 4100007
Seongnam-si, Gyeonggi-do, South Korea
Investigational Site Number : 4100002
Seoul, Seoul-teukbyeolsi, South Korea
Investigational Site Number : 4100004
Seoul, Seoul-teukbyeolsi, South Korea
Investigational Site Number : 4100003
Seoul, Seoul-teukbyeolsi, South Korea
Investigational Site Number : 7240018
Murcia, Almería, Spain
Investigational Site Number : 7240016
Barcelona, Barcelona [Barcelona], Spain
Investigational Site Number : 7240010
Barcelona, Barcelona [Barcelona], Spain
Investigational Site Number : 7240009
Barakaldo, Basque Country, Spain
Investigational Site Number : 7240011
L'Hospitalet de Llobregat, Catalunya [Cataluña], Spain
Investigational Site Number : 7240012
Donostia / San Sebastian, Gipuzkoa, Spain
Investigational Site Number : 7240024
Girona, Girona [Gerona], Spain
Investigational Site Number : 7240013
Las Palmas de Gran Canaria, Las Palmas, Spain
Investigational Site Number : 7240015
Lleida, Lleida [Lérida], Spain
Investigational Site Number : 7240017
Majadahonda, Madrid, Spain
Investigational Site Number : 7240001
Pozuelo de Alarcón, Madrid, Spain
Investigational Site Number : 7240014
Pontevedra, Pontevedra [Pontevedra], Spain
Investigational Site Number : 7240007
Seville, Sevilla, Spain
Investigational Site Number : 7240004
Córdoba, , Spain
Investigational Site Number : 7240006
Madrid, , Spain
Investigational Site Number : 7240023
Madrid, , Spain
Investigational Site Number : 7240002
Madrid, , Spain
Investigational Site Number : 7240003
Madrid, , Spain
Investigational Site Number : 7240022
Madrid, , Spain
Investigational Site Number : 7240005
Málaga, , Spain
Investigational Site Number : 7240008
Valencia, , Spain
Investigational Site Number : 7240025
Zaragoza, , Spain
Investigational Site Number : 7520001
Gothenburg, , Sweden
Investigational Site Number : 7520005
Huddinge, , Sweden
Investigational Site Number : 7520003
Malmo, , Sweden
Investigational Site Number : 7520002
Stockholm, , Sweden
Investigational Site Number : 7920018
Ankara, , Turkey (Türkiye)
Investigational Site Number : 7920011
Ankara, , Turkey (Türkiye)
Investigational Site Number : 7920020
Bursa, , Turkey (Türkiye)
Investigational Site Number : 7920013
Bursa, , Turkey (Türkiye)
Investigational Site Number : 7920005
Eskişehir, , Turkey (Türkiye)
Investigational Site Number : 7920012
Istanbul, , Turkey (Türkiye)
Investigational Site Number : 7920002
Istanbul, , Turkey (Türkiye)
Investigational Site Number : 7920016
Istanbul, , Turkey (Türkiye)
Investigational Site Number : 7920009
Istanbul, , Turkey (Türkiye)
Investigational Site Number : 7920007
Istanbul, , Turkey (Türkiye)
Investigational Site Number : 7920019
Izmir, , Turkey (Türkiye)
Investigational Site Number : 7920008
Izmir, , Turkey (Türkiye)
Investigational Site Number : 7920001
İzmit, , Turkey (Türkiye)
Investigational Site Number : 7920014
Kayseri, , Turkey (Türkiye)
Investigational Site Number : 7920015
Konya, , Turkey (Türkiye)
Investigational Site Number : 7920006
Mersin, , Turkey (Türkiye)
Investigational Site Number : 7920004
Samsun, , Turkey (Türkiye)
Investigational Site Number : 7920003
Sultangazi, , Turkey (Türkiye)
Investigational Site Number : 7920017
Van, , Turkey (Türkiye)
Investigational Site Number : 8040001
Chernivtsi, , Ukraine
Investigational Site Number : 8040009
Ivano-Frankivsk, , Ukraine
Investigational Site Number : 8040003
Ivano-Frankivsk, , Ukraine
Investigational Site Number : 8040006
Kyiv, , Ukraine
Investigational Site Number : 8040008
Lutsk, , Ukraine
Investigational Site Number : 8040004
Lviv, , Ukraine
Investigational Site Number : 8040002
Lviv, , Ukraine
Investigational Site Number : 8040005
Vinnytsia, , Ukraine
Investigational Site Number : 8260011
Gwent, Blaenau Gwent, United Kingdom
Investigational Site Number : 8260001
Exeter, Devon, United Kingdom
Investigational Site Number : 8260013
London, England, United Kingdom
Investigational Site Number : 8260006
Newcastle upon Tyne, England, United Kingdom
Investigational Site Number : 8260010
Inverness, Highland, United Kingdom
Investigational Site Number : 8260003
Canterbury, Kent, United Kingdom
Investigational Site Number : 8260008
Salford, Manchester, United Kingdom
Investigational Site Number : 8260004
Oxford, Oxfordshire, United Kingdom
Investigational Site Number : 8260005
Swansea, Swansea [Abertawe Gb-ata], United Kingdom
Investigational Site Number : 8260007
Cardiff, Vale of Glamorgan, the, United Kingdom
Investigational Site Number : 8260009
Liverpool, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Trial Transparency email recommended (Toll free number for US & Canada)
Role: CONTACT
Related Links
Access external resources that provide additional context or updates about the study.
Multiple Sclerosis Website
EFC17504 Plain Language Results Summary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U1111-1280-7114
Identifier Type: REGISTRY
Identifier Source: secondary_id
2023-504359-29
Identifier Type: REGISTRY
Identifier Source: secondary_id
EFC17504
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.